{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:09:35Z","timestamp":1777936175989,"version":"3.51.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Medical Center Rotterdam"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose of Review<\/jats:title><jats:p>We aim to summarize recent insights and provide an up-to-date overview on the role of intra-aortic balloon pump (IABP) counterpulsation in cardiogenic shock (CS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Recent Findings<\/jats:title><jats:p>In the largest randomized controlled trial (RCT) of patients with CS after acute myocardial infarction (AMICS), IABP did not lower mortality. However, recent data suggest a role for IABP in patients who have persistent ischemia after revascularization. Moreover, in the growing population of CS not caused by acute coronary syndrome (ACS), multiple retrospective studies and one small RCT report on significant hemodynamic improvement following (early) initiation of IABP support, which allowed bridging of most patients to recovery or definitive therapies like heart transplant or a left ventricular assist device (LVAD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>Routine use of IABP in patients with AMICS is not recommended, but many patients with CS either from ischemic or non-ischemic cause may benefit from IABP at least for hemodynamic improvement in the short term. There is a need for a larger RCT regarding the role of IABP in selected patients with ACS, as well as in patients with non-ACS CS.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s11897-020-00480-0","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T09:02:43Z","timestamp":1598950963000},"page":"247-260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Mechanical Support in Early Cardiogenic Shock: What Is the Role of Intra-aortic Balloon Counterpulsation?"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8206-1664","authenticated-orcid":false,"given":"Jesse R.","family":"Kimman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas M.","family":"Van Mieghem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Endeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper J.","family":"Brugts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina A.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier C.","family":"Manintveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corstiaan A.","family":"den Uil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"issue":"4","key":"480_CR1","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.hlc.2018.03.025","volume":"28","author":"R Doshi","year":"2019","unstructured":"Doshi R, Patel K, Decter D, Gupta R, Meraj P. Trends in the utilisation and in-hospital mortality associated with short-term mechanical circulatory support for heart failure with reduced ejection fraction. Heart Lung Circ. 2019;28(4):e47\u201350.","journal-title":"Heart Lung Circ"},{"issue":"4","key":"480_CR2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00392-017-1182-2","volume":"107","author":"M Shah","year":"2018","unstructured":"Shah M, Patnaik S, Patel B, Ram P, Garg L, Agarwal M, et al. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol. 2018;107(4):287\u2013303.","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"480_CR3","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.athoracsur.2009.11.082","volume":"90","author":"J Raman","year":"2010","unstructured":"Raman J, Loor G, London M, Jolly N. Subclavian artery access for ambulatory balloon pump insertion. Ann Thorac Surg. 2010;90(3):1032\u20134.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"480_CR4","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.athoracsur.2015.05.087","volume":"100","author":"A Tanaka","year":"2015","unstructured":"Tanaka A, Tuladhar SM, Onsager D, Asfaw Z, Ota T, Juricek C, et al. The subclavian intraaortic balloon pump: a compelling bridge device for advanced heart failure. Ann Thorac Surg. 2015;100(6):2151\u20137 discussion 7-8.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"480_CR5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jtcvs.2012.03.007","volume":"144","author":"MJ Russo","year":"2012","unstructured":"Russo MJ, Jeevanandam V, Stepney J, Merlo A, Johnson EM, Malyala R, et al. Intra-aortic balloon pump inserted through the subclavian artery: a minimally invasive approach to mechanical support in the ambulatory end-stage heart failure patient. J Thorac Cardiovasc Surg. 2012;144(4):951\u20135.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"480_CR6","first-page":"56","volume":"30","author":"T Imamura","year":"2018","unstructured":"\u2022 Imamura T, Juricek C, Nguyen A, Chung B, Rodgers D, Sayer G, et al. Predictors of hemodynamic improvement and stabilization following intraaortic balloon pump implantation in patients with advanced heart failure. J Invasive Cardiol. 2018;30(2):56\u201361. This study showed that subclavian IABP can provide long lasting hemodynamic stabilization in instable patients with ADHF, and thereby allow a bridge to recovery or more durable heart replacement therapies.","journal-title":"J Invasive Cardiol"},{"issue":"4","key":"480_CR7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jchf.2020.01.011","volume":"8","author":"A Bhimaraj","year":"2020","unstructured":"\u2022 Bhimaraj A, Agrawal T, Duran A, Tamimi O, Amione-Guerra J, Trachtenberg B, et al. Percutaneous left axillary artery placement of intra-aortic balloon pump in advanced heart failure patients. JACC Heart Fail. 2020;8(4):313\u201323. This study showed that percutaneously placed IABP is an efficient bridge to heart replacement therapies in patients with advanced heart failure who need mechanical support.","journal-title":"JACC Heart Fail"},{"issue":"12","key":"480_CR8","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/eurheartj\/ehz552","volume":"41","author":"MB Bastos","year":"2020","unstructured":"Bastos MB, Burkhoff D, Maly J, Daemen J, den Uil CA, Ameloot K, et al. Invasive left ventricle pressure-volume analysis: overview and practical clinical implications. Eur Heart J. 2020;41(12):1286\u201397.","journal-title":"Eur Heart J"},{"issue":"3","key":"480_CR9","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.athoracsur.2004.07.073","volume":"79","author":"JJ Schreuder","year":"2005","unstructured":"Schreuder JJ, Maisano F, Donelli A, Jansen JR, Hanlon P, Bovelander J, et al. Beat-to-beat effects of intraaortic balloon pump timing on left ventricular performance in patients with low ejection fraction. Ann Thorac Surg. 2005;79(3):872\u201380.","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"480_CR10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cardfail.2017.05.015","volume":"23","author":"SK Annamalai","year":"2017","unstructured":"Annamalai SK, Buiten L, Esposito ML, Paruchuri V, Mullin A, Breton C, et al. Acute hemodynamic effects of intra-aortic balloon counterpulsation pumps in advanced heart failure. J Card Fail. 2017;23(8):606\u201314.","journal-title":"J Card Fail"},{"issue":"12","key":"480_CR11","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jama.2011.1280","volume":"306","author":"MR Patel","year":"2011","unstructured":"Patel MR, Smalling RW, Thiele H, Barnhart HX, Zhou Y, Chandra P, et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA. 2011;306(12):1329\u201337.","journal-title":"JAMA."},{"issue":"6","key":"480_CR12","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamainternmed.2015.0569","volume":"175","author":"Y Ahmad","year":"2015","unstructured":"Ahmad Y, Sen S, Shun-Shin MJ, Ouyang J, Finegold JA, Al-Lamee RK, et al. Intra-aortic balloon pump therapy for acute myocardial infarction: a meta-analysis. JAMA Intern Med. 2015;175(6):931\u20139.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"480_CR13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ccd.28289","volume":"95","author":"LX van Nunen","year":"2020","unstructured":"van Nunen LX, van 't Veer M, Zimmermann FM, Wijnbergen I, Brueren GRG, Tonino PAL, et al. Intra-aortic balloon pump counterpulsation in extensive myocardial infarction with persistent ischemia: the SEMPER FI pilot study. Catheter Cardiovasc Interv. 2020;95(1):128\u201335.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"480_CR14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCULATIONAHA.112.132209","volume":"127","author":"D Perera","year":"2013","unstructured":"Perera D, Stables R, Clayton T, De Silva K, Lumley M, Clack L, et al. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation. 2013;127(2):207\u201312.","journal-title":"Circulation."},{"issue":"14","key":"480_CR15","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","volume":"126","author":"WW O\u2019Neill","year":"2012","unstructured":"O\u2019Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012;126(14):1717\u201327.","journal-title":"Circulation."},{"issue":"37","key":"480_CR16","doi-asserted-by":"crossref","first-page":"e17107","DOI":"10.1097\/MD.0000000000017107","volume":"98","author":"W Shi","year":"2019","unstructured":"Shi W, Wang W, Wang K, Huang W. Percutaneous mechanical circulatory support devices in high-risk patients undergoing percutaneous coronary intervention: a meta-analysis of randomized trials. Medicine (Baltimore). 2019;98(37):e17107.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"480_CR17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ccd.28383","volume":"95","author":"Y Al-Khadra","year":"2020","unstructured":"Al-Khadra Y, Alraies MC, Darmoch F, Pacha HM, Soud M, Kaki A, et al. Outcomes of nonemergent percutaneous coronary intervention requiring mechanical circulatory support in patients without cardiogenic shock. Catheter Cardiovasc Interv. 2020;95(3):503\u201312.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"480_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jocs.13114","volume":"32","author":"AC Deppe","year":"2017","unstructured":"Deppe AC, Weber C, Liakopoulos OJ, Zeriouh M, Slottosch I, Scherner M, et al. Preoperative intra-aortic balloon pump use in high-risk patients prior to coronary artery bypass graft surgery decreases the risk for morbidity and mortality-a meta-analysis of 9,212 patients. J Card Surg. 2017;32(3):177\u201385.","journal-title":"J Card Surg"},{"issue":"1","key":"480_CR19","first-page":"2","volume":"30","author":"PP Rampersad","year":"2018","unstructured":"Rampersad PP, Udell JA, Zawi R, Ouzounian M, Overgaard CB, Sharma V, et al. Preoperative intraaortic balloon pump improves early outcomes following high-risk coronary artery bypass graft surgery: a meta-analysis of randomized trials and prospective study design. J Invasive Cardiol. 2018;30(1):2\u20139.","journal-title":"J Invasive Cardiol"},{"key":"480_CR20","doi-asserted-by":"crossref","unstructured":"Escutia-Cuevas HH, Suarez-Cuenca JA, Espinoza-Rueda MA, Macedo-Calvillo L, Castro-Gutierrez A, Garcia-Garcia JF, et al. Preoperative use of intra-aortic balloon pump support reduced 30-day mortality in a population with LVEF >35% and high surgical risk after coronary artery bypass graft surgery. Cardiology. 2020;145(5):267\u2013274.","DOI":"10.1159\/000506393"},{"issue":"11","key":"480_CR21","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1097\/CCM.0b013e3182978dfc","volume":"41","author":"M Ranucci","year":"2013","unstructured":"Ranucci M, Castelvecchio S, Biondi A, de Vincentiis C, Ballotta A, Varrica A, et al. A randomized controlled trial of preoperative intra-aortic balloon pump in coronary patients with poor left ventricular function undergoing coronary artery bypass surgery*. Crit Care Med. 2013;41(11):2476\u201383.","journal-title":"Crit Care Med"},{"issue":"9","key":"480_CR22","doi-asserted-by":"crossref","first-page":"e006930","DOI":"10.1161\/CIRCINTERVENTIONS.118.006930","volume":"11","author":"S Vallabhajosyula","year":"2018","unstructured":"Vallabhajosyula S, O\u2019Horo JC, Antharam P, Ananthaneni S, Vallabhajosyula S, Stulak JM, et al. Concomitant intra-aortic balloon pump use in cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation. Circ Cardiovasc Interv. 2018;11(9):e006930.","journal-title":"Circ Cardiovasc Interv"},{"key":"480_CR23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2020.02.004","volume":"312","author":"L Baldetti","year":"2020","unstructured":"Baldetti L, Gramegna M, Beneduce A, Melillo F, Moroni F, Calvo F, et al. Strategies of left ventricular unloading during VA-ECMO support: a network meta-analysis. Int J Cardiol. 2020;312:16\u201321.","journal-title":"Int J Cardiol"},{"issue":"2","key":"480_CR24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119\u201377.","journal-title":"Eur Heart J"},{"issue":"11","key":"480_CR25","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.amjcard.2013.07.035","volume":"112","author":"J Kettner","year":"2013","unstructured":"Kettner J, Sramko M, Holek M, Pirk J, Kautzner J. Utility of intra-aortic balloon pump support for ventricular septal rupture and acute mitral regurgitation complicating acute myocardial infarction. Am J Cardiol. 2013;112(11):1709\u201313.","journal-title":"Am J Cardiol"},{"key":"480_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ahj.2017.11.016","volume":"199","author":"S Hsu","year":"2018","unstructured":"\u2022 Hsu S, Kambhampati S, Sciortino CM, Russell SD, Schulman SP. Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock. Am Heart J. 2018;199:181\u201391. This is one of the largest retrospective cohort studies regarding patients with non-ACS cardiogenic shock receiving femoral IABP.","journal-title":"Am Heart J"},{"issue":"5","key":"480_CR27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.amjcard.2018.11.041","volume":"123","author":"B Gul","year":"2019","unstructured":"Gul B, Bellumkonda L. Usefulness of intra-aortic balloon pump in patients with cardiogenic shock. Am J Cardiol. 2019;123(5):750\u20136.","journal-title":"Am J Cardiol"},{"issue":"11","key":"480_CR28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.healun.2018.03.011","volume":"37","author":"JA Fried","year":"2018","unstructured":"\u2022 Fried JA, Nair A, Takeda K, Clerkin K, Topkara VK, Masoumi A, et al. Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock. J Heart Lung Transplant. 2018;37(11):1313\u201321. This is the largest retrospective cohort study of femoral IABP in patients with non-ACS cardiogenic shock.","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"480_CR29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0267659117727825","volume":"33","author":"MM de Jong","year":"2018","unstructured":"de Jong MM, Lorusso R, Al Awami F, Matteuci F, Parise O, Lozekoot P, et al. Vascular complications following intra-aortic balloon pump implantation: an updated review. Perfusion. 2018;33(2):96\u2013104.","journal-title":"Perfusion."},{"issue":"7","key":"480_CR30","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4244\/EIJ-D-19-00254","volume":"15","author":"CA den Uil","year":"2019","unstructured":"\u2022\u2022 den Uil CA, Van Mieghem NM, Bastos MB, Jewbali LS, Lenzen MJ, Engstrom AE, et al. Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial. EuroIntervention. 2019;15(7):586\u201393. This is the first and only randomized controlled trial comparing primary IABP support versus inotropes in non-ACS cardiogenic shock.","journal-title":"EuroIntervention"},{"issue":"14","key":"480_CR31","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","volume":"367","author":"H Thiele","year":"2012","unstructured":"Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287\u201396.","journal-title":"N Engl J Med"},{"issue":"5","key":"480_CR32","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jtcvs.2012.02.009","volume":"143","author":"R Umakanthan","year":"2012","unstructured":"Umakanthan R, Hoff SJ, Solenkova N, Wigger MA, Keebler ME, Lenneman A, et al. Benefits of ambulatory axillary intra-aortic balloon pump for circulatory support as bridge to heart transplant. J Thorac Cardiovasc Surg. 2012;143(5):1193\u20137.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"480_CR33","doi-asserted-by":"crossref","first-page":"e001214","DOI":"10.1136\/openhrt-2019-001214","volume":"7","author":"OKL Helgestad","year":"2020","unstructured":"Helgestad OKL, Josiassen J, Hassager C, Jensen LO, Holmvang L, Udesen NLJ, et al. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock. Open Heart. 2020;7(1):e001214.","journal-title":"Open Heart"},{"key":"480_CR34","unstructured":"Vallabhajosyula S, Prasad A, Sandhu GS, Bell MR, Gulati R, Eleid MF, et al. Mechanical circulatory support-assisted early percutaneous coronary intervention in acute myocardial infarction with cardiogenic shock: 10-year national temporal trends, predictors and outcomes. EuroIntervention. 2019;EIJ-D-19-00226."},{"issue":"3","key":"480_CR35","first-page":"CD007398","volume":"27","author":"S Unverzagt","year":"2015","unstructured":"Unverzagt S, Buerke M, de Waha A, Haerting J, Pietzner D, Seyfarth M, et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev. 2015;27(3):CD007398.","journal-title":"Cochrane Database Syst Rev"},{"issue":"27","key":"480_CR36","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"16","key":"480_CR37","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","volume":"136","author":"S van Diepen","year":"2017","unstructured":"van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136(16):e232\u2013e68.","journal-title":"Circulation."},{"issue":"11","key":"480_CR38","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/clc.23264","volume":"42","author":"K Cui","year":"2019","unstructured":"Cui K, Lyu S, Liu H, Song X, Yuan F, Xu F, et al. Timing of initiation of intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: a meta-analysis. Clin Cardiol. 2019;42(11):1126\u201334.","journal-title":"Clin Cardiol"},{"issue":"6","key":"480_CR39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/joic.12569","volume":"31","author":"M Pieri","year":"2018","unstructured":"Pieri M, Sorrentino T, Oppizzi M, Melisurgo G, Lembo R, Colombo A, et al. The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock. J Interv Cardiol. 2018;31(6):717\u201324.","journal-title":"J Interv Cardiol"},{"issue":"47","key":"480_CR40","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/eurheartj\/ehx363","volume":"38","author":"H Thiele","year":"2017","unstructured":"Thiele H, Jobs A, Ouweneel DM, Henriques JPS, Seyfarth M, Desch S, et al. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J. 2017;38(47):3523\u201331.","journal-title":"Eur Heart J"},{"issue":"3","key":"480_CR41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","volume":"69","author":"DM Ouweneel","year":"2017","unstructured":"Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJ, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69(3):278\u201387.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"480_CR42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.118.036614","volume":"139","author":"B Schrage","year":"2019","unstructured":"Schrage B, Ibrahim K, Loehn T, Werner N, Sinning JM, Pappalardo F, et al. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation. 2019;139(10):1249\u201358.","journal-title":"Circulation."},{"key":"480_CR43","doi-asserted-by":"crossref","unstructured":"Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, et al. Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2020;e200254.","DOI":"10.1001\/jama.2020.0254"},{"issue":"4","key":"480_CR44","first-page":"182","volume":"27","author":"NK Kapur","year":"2015","unstructured":"Kapur NK, Paruchuri V, Majithia A, Esposito M, Shih H, Weintraub A, et al. Hemodynamic effects of standard versus larger-capacity intraaortic balloon counterpulsation pumps. J Invasive Cardiol. 2015;27(4):182\u20138.","journal-title":"J Invasive Cardiol"},{"issue":"4","key":"480_CR45","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1002\/ccd.26908","volume":"90","author":"GK Visveswaran","year":"2017","unstructured":"Visveswaran GK, Cohen M, Seliem A, DiVita M, McNamara JKR, Dave A, et al. A single center tertiary care experience utilizing the large volume mega 50cc intra-aortic balloon counterpulsation in contemporary clinical practice. Catheter Cardiovasc Interv. 2017;90(4):E63\u201372.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"480_CR46","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ccd.27387","volume":"92","author":"DA Baran","year":"2018","unstructured":"Baran DA, Visveswaran GK, Seliem A, DiVita M, Wasty N, Cohen M. Differential responses to larger volume intra-aortic balloon counterpulsation: hemodynamic and clinical outcomes. Catheter Cardiovasc Interv. 2018;92(4):703\u201310.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"480_CR47","doi-asserted-by":"crossref","first-page":"e005618","DOI":"10.1161\/CIRCOUTCOMES.119.005618","volume":"12","author":"DD Berg","year":"2019","unstructured":"Berg DD, Bohula EA, van Diepen S, Katz JN, Alviar CL, Baird-Zars VM, et al. Epidemiology of shock in contemporary cardiac intensive care units. Circ Cardiovasc Qual Outcomes. 2019;12(3):e005618.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"480_CR48","doi-asserted-by":"crossref","unstructured":"Schrage B, Weimann J, Dabboura S, Yan I, Hilal R, Becher PM, et al. Patient characteristics, treatment and outcome in non-ischemic vs. ischemic cardiogenic shock. J Clin Med. 2020;9(4):931.","DOI":"10.3390\/jcm9040931"},{"issue":"5","key":"480_CR49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","volume":"17","author":"VP Harjola","year":"2015","unstructured":"Harjola VP, Lassus J, Sionis A, Kober L, Tarvasmaki T, Spinar J, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17(5):501\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"480_CR50","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.amjcard.2019.09.016","volume":"124","author":"W Malick","year":"2019","unstructured":"\u2022\u2022 Malick W, Fried JA, Masoumi A, Nair A, Zuver A, Huang A, et al. Comparison of the hemodynamic response to intra-aortic balloon counterpulsation in patients with cardiogenic shock resulting from acute myocardial infarction versus acute decompensated heart failure. Am J Cardiol. 2019;124(12):1947\u201353. This study directly compared the hemodynamic response to IABP between patients with AMICS and patients with non-ACS CS.","journal-title":"Am J Cardiol"},{"issue":"1","key":"480_CR51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1510\/icvts.2006.140160","volume":"6","author":"I Norkiene","year":"2007","unstructured":"Norkiene I, Ringaitiene D, Rucinskas K, Samalavicius R, Baublys A, Miniauskas S, et al. Intra-aortic balloon counterpulsation in decompensated cardiomyopathy patients: bridge to transplantation or assist device. Interact Cardiovasc Thorac Surg. 2007;6(1):66\u201370.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"7","key":"480_CR52","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/eurjhf\/hfp078","volume":"11","author":"O Gjesdal","year":"2009","unstructured":"Gjesdal O, Gude E, Arora S, Leivestad T, Andreassen AK, Gullestad L, et al. Intra-aortic balloon counterpulsation as a bridge to heart transplantation does not impair long-term survival. Eur J Heart Fail. 2009;11(7):709\u201314.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"480_CR53","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.ijcard.2014.08.154","volume":"176","author":"M Mizuno","year":"2014","unstructured":"Mizuno M, Sato N, Kajimoto K, Sakata Y, Minami Y, Munakata R, et al. Intra-aortic balloon counterpulsation for acute decompensated heart failure. Int J Cardiol. 2014;176(3):1444\u20136.","journal-title":"Int J Cardiol"},{"key":"480_CR54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijcard.2015.05.014","volume":"192","author":"A Ntalianis","year":"2015","unstructured":"Ntalianis A, Kapelios CJ, Kanakakis J, Repasos E, Pantsios C, Nana E, et al. Prolonged intra-aortic balloon pump support in biventricular heart failure induces right ventricular reverse remodeling. Int J Cardiol. 2015;192:3\u20138.","journal-title":"Int J Cardiol"},{"issue":"11","key":"480_CR55","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cardfail.2015.06.383","volume":"21","author":"MA Sintek","year":"2015","unstructured":"Sintek MA, Gdowski M, Lindman BR, Nassif M, Lavine KJ, Novak E, et al. Intra-aortic balloon counterpulsation in patients with chronic heart failure and cardiogenic shock: clinical response and predictors of stabilization. J Card Fail. 2015;21(11):868\u201376.","journal-title":"J Card Fail"},{"issue":"1","key":"480_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000471846","volume":"138","author":"CA den Uil","year":"2017","unstructured":"den Uil CA, Galli G, Jewbali LS, Caliskan K, Manintveld OC, Brugts JJ, et al. First-line support by intra-aortic balloon pump in non-ischaemic cardiogenic shock in the era of modern ventricular assist devices. Cardiology. 2017;138(1):1\u20138.","journal-title":"Cardiology."},{"key":"480_CR57","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ahj.2018.07.009","volume":"204","author":"N Morici","year":"2018","unstructured":"Morici N, Oliva F, Ajello S, Stucchi M, Sacco A, Cipriani MG, et al. Management of cardiogenic shock in acute decompensated chronic heart failure: the ALTSHOCK phase II clinical trial. Am Heart J. 2018;204:196\u2013201.","journal-title":"Am Heart J"},{"issue":"16","key":"480_CR58","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/heartjnl-2012-301963","volume":"98","author":"DM Ouweneel","year":"2012","unstructured":"Ouweneel DM, Henriques JP. Percutaneous cardiac support devices for cardiogenic shock: current indications and recommendations. Heart. 2012;98(16):1246\u201354.","journal-title":"Heart."},{"issue":"1","key":"480_CR59","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ejcts\/ezx088","volume":"52","author":"CA den Uil","year":"2017","unstructured":"den Uil CA, Akin S, Jewbali LS, Dos Reis MD, Brugts JJ, Constantinescu AA, et al. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2017;52(1):14\u201325.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"18","key":"480_CR60","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.jcin.2018.07.030","volume":"11","author":"M Hawranek","year":"2018","unstructured":"\u2022 Hawranek M, Gierlotka M, Pres D, Zembala M, Gasior M. Nonroutine use of intra-aortic balloon pump in cardiogenic shock complicating myocardial infarction with successful and unsuccessful primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2018;11(18):1885\u201393. This study is interesting since it showed that patients with AMICS but unsuccessful primary PCI might still benefit from IABP therapy.","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"480_CR61","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67\u2013e492.","journal-title":"Circulation."},{"issue":"4","key":"480_CR62","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SHK.0b013e31824a67af","volume":"37","author":"R Prondzinsky","year":"2012","unstructured":"Prondzinsky R, Unverzagt S, Russ M, Lemm H, Swyter M, Wegener N, et al. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock. 2012;37(4):378\u201384.","journal-title":"Shock."},{"issue":"13","key":"480_CR63","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/eurheartj\/ehi161","volume":"26","author":"H Thiele","year":"2005","unstructured":"Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26(13):1276\u201383.","journal-title":"Eur Heart J"},{"issue":"19","key":"480_CR64","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","volume":"52","author":"M Seyfarth","year":"2008","unstructured":"Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52(19):1584\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"480_CR65","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ccd.27878","volume":"92","author":"NK Kapur","year":"2018","unstructured":"Kapur NK, Hirst CS. Counterpulsation requires pulsation: IABP use in patients with heart failure without acute MI. Catheter Cardiovasc Interv. 2018;92(4):711\u20132.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"11","key":"480_CR66","first-page":"583","volume":"24","author":"P Lauten","year":"2012","unstructured":"Lauten P, Rademacher W, Goebel B, Kretzschmar D, Figulla HR, Lauten A, et al. Intra-aortic counterpulsation for hemodynamic support in patients with acute ischemic versus non-ischemic heart failure. J Invasive Cardiol. 2012;24(11):583\u20138.","journal-title":"J Invasive Cardiol"},{"issue":"4","key":"480_CR67","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.healun.2019.12.011","volume":"39","author":"VK Ton","year":"2020","unstructured":"\u2022\u2022 Ton VK, Xie R, Hernandez-Montfort JA, Meyns B, Nakatani T, Yanase M, et al. Short- and long-term adverse events in patients on temporary circulatory support before durable ventricular assist device: An IMACS registry analysis. J Heart Lung Transplant. 2020;39(4):342\u201352. This study showed that patients who needed IABP as a bridge to LVAD had similar short- and long-term survival compared to hemodynamical stable patients receiving LVADs, suggesting that temporary stabilization by IABP gives perspective to long-term survival.","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"480_CR68","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1177\/2048872616652262","volume":"6","author":"A Krishnamoorthy","year":"2017","unstructured":"Krishnamoorthy A, DeVore AD, Sun JL, Barnett AS, Samsky MD, Shaw LK, et al. The impact of a failing right heart in patients supported by intra-aortic balloon counterpulsation. Eur Heart J Acute Cardiovasc Care. 2017;6(8):709\u201318.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"20","key":"480_CR69","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.jacc.2014.01.016","volume":"63","author":"GS Francis","year":"2014","unstructured":"Francis GS, Bartos JA, Adatya S. Inotropes. J Am Coll Cardiol. 2014;63(20):2069\u201378.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"480_CR70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","volume":"46","author":"WT Abraham","year":"2005","unstructured":"Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005;46(1):57\u201364.","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-020-00480-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11897-020-00480-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-020-00480-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T14:12:08Z","timestamp":1668348728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11897-020-00480-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["480"],"URL":"https:\/\/doi.org\/10.1007\/s11897-020-00480-0","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"1 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Van Mieghem reports grants and personal fees from PulseCath BV, grants and personal fees from Abbott Vascular, grants and personal fees from Medtronic, grants and personal fees from Biotronik, grants and personal fees from Boston Scientific, and personal fees from Abiomed, all outside the submitted work. All other authors declare no conflicts of interest related to the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}